1. Home
  2. AZI vs IMAB Comparison

AZI vs IMAB Comparison

Compare AZI & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZI
  • IMAB
  • Stock Information
  • Founded
  • AZI 2010
  • IMAB 2014
  • Country
  • AZI China
  • IMAB United States
  • Employees
  • AZI 86
  • IMAB N/A
  • Industry
  • AZI
  • IMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZI
  • IMAB Health Care
  • Exchange
  • AZI Nasdaq
  • IMAB Nasdaq
  • Market Cap
  • AZI 23.8M
  • IMAB 200.9M
  • IPO Year
  • AZI 2024
  • IMAB 2020
  • Fundamental
  • Price
  • AZI $0.23
  • IMAB $2.16
  • Analyst Decision
  • AZI
  • IMAB Strong Buy
  • Analyst Count
  • AZI 0
  • IMAB 2
  • Target Price
  • AZI N/A
  • IMAB $6.00
  • AVG Volume (30 Days)
  • AZI 812.1K
  • IMAB 982.8K
  • Earning Date
  • AZI 01-27-2025
  • IMAB 05-15-2025
  • Dividend Yield
  • AZI N/A
  • IMAB N/A
  • EPS Growth
  • AZI N/A
  • IMAB N/A
  • EPS
  • AZI N/A
  • IMAB N/A
  • Revenue
  • AZI $124,737,000.00
  • IMAB N/A
  • Revenue This Year
  • AZI N/A
  • IMAB N/A
  • Revenue Next Year
  • AZI N/A
  • IMAB N/A
  • P/E Ratio
  • AZI N/A
  • IMAB N/A
  • Revenue Growth
  • AZI 9.86
  • IMAB N/A
  • 52 Week Low
  • AZI $0.19
  • IMAB $0.60
  • 52 Week High
  • AZI $4.05
  • IMAB $3.08
  • Technical
  • Relative Strength Index (RSI)
  • AZI N/A
  • IMAB 50.70
  • Support Level
  • AZI N/A
  • IMAB $2.00
  • Resistance Level
  • AZI N/A
  • IMAB $2.95
  • Average True Range (ATR)
  • AZI 0.00
  • IMAB 0.34
  • MACD
  • AZI 0.00
  • IMAB -0.08
  • Stochastic Oscillator
  • AZI 0.00
  • IMAB 15.79

About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

Share on Social Networks: